NKF(SH:603707) Shang Hai Zheng Quan Bao·2025-12-05 20:17Group 1 - The company, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., issued 5,031,900 convertible bonds with a total amount of RMB 503.19 million, which are set to mature on April 22, 2026 [1] - The initial conversion price of the convertible bonds was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing it down to RMB 24.54 per share as of July 7, 2023 [2] - The company’s board has the authority to propose a downward adjustment of the conversion price if the stock price falls below 90% of the current conversion price for at least 15 out of 30 consecutive trading days [3] Group 2 - The company decided not to adjust the conversion price of the convertible bonds during the upcoming six months, even if the conditions for adjustment are met [4] - If the stock price continues to fall and triggers the adjustment conditions after November 24, 2025, the board will reconvene to decide on the potential adjustment [5]